From Casetext: Smarter Legal Research

Astrazeneca LP v. Mylan Pharmaceuticals Inc.

United States Court of Appeals for the Federal Circuit
Apr 9, 2012
467 F. App'x 885 (Fed. Cir. 2012)

Opinion

2011-1506

04-09-2012

ASTRAZENECA LP, AKTIEBOLAGET DRACO, KBI INC., AND KBI-E INC., Plaintiffs-Appellants, v. MYLAN PHARMACEUTICALS INC., Defendant-Appellee.

GEORGE F. PAPPAS, Covington & Burling LLP, of Washington, DC, argued for plaintiffs-appellants. With him on the brief were JEFFREY B. ELIKAN and MICHELLE L. MORIN. NICOLE W. STAFFORD, Wilson Sonsini Goodrich & Rosati, of Austin, Texas, argued for defendant-appellee. With her on the brief were ROBERT DELAFIELD; DAVID S. STEUER and MATTHEW A. ARGENTI, of Palo Alto, California.


NOTE: This disposition is nonprecedential.


Appeal from the United States District Court for the District of Delaware in No. 08-CV-0453, Chief Judge Gregory M. Sleet.

JUDGMENT

GEORGE F. PAPPAS, Covington & Burling LLP, of Washington, DC, argued for plaintiffs-appellants. With him on the brief were JEFFREY B. ELIKAN and MICHELLE L. MORIN.

NICOLE W. STAFFORD, Wilson Sonsini Goodrich & Rosati, of Austin, Texas, argued for defendant-appellee. With her on the brief were ROBERT DELAFIELD; DAVID S. STEUER and MATTHEW A. ARGENTI, of Palo Alto, California.

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (RADER, Chief Judge, PLAGER and LOURIE, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

_________________

Jan Horbaly

Clerk


Summaries of

Astrazeneca LP v. Mylan Pharmaceuticals Inc.

United States Court of Appeals for the Federal Circuit
Apr 9, 2012
467 F. App'x 885 (Fed. Cir. 2012)
Case details for

Astrazeneca LP v. Mylan Pharmaceuticals Inc.

Case Details

Full title:ASTRAZENECA LP, AKTIEBOLAGET DRACO, KBI INC., AND KBI-E INC.…

Court:United States Court of Appeals for the Federal Circuit

Date published: Apr 9, 2012

Citations

467 F. App'x 885 (Fed. Cir. 2012)